Jazz Pharmaceuticals agrees $225.0M share repurchase via private transactions
Jazz Pharmaceuticals also agreed to a concurrent $225.0M share repurchase from note purchasers in privately negotiated transactions.
Story updates
04:49:59 AM UTC
SquawkNews
Jazz Pharmaceuticals' Concurrent Buyback to Reduce Remaining Amount Under Share Repurchase Program >JAZZ
04:50:32 AM UTC
SquawkNews
Jazz Pharmaceuticals: Closing of Notes Isn't Contingent Upon Closing of Concurrent Shr Repurchases >JAZZ
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.